Selected article for: "dna virus and RNA genome"

Author: Yu, Lan; Tian, Xun; Gao, Chun; Wu, Ping; Wang, Liming; Feng, Bei; Li, Xiaomin; Wang, Hui; Ma, Ding; Hu, Zheng
Title: Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas
  • Cord-id: 4ky9tu5x
  • Document date: 2018_4_12
  • ID: 4ky9tu5x
    Snippet: Viral infections cause at least 10%–15% of all human carcinomas. Over the last century, the elucidation of viral oncogenic roles in many cancer types has provided fundamental knowledge on carcinogenetic mechanisms and established a basis for the early intervention of virus-related cancers. Meanwhile, rapidly evolving genome-editing techniques targeting viral DNA/RNA have emerged as novel therapeutic strategies for treating virus-related carcinogenesis and have begun showing promising results.
    Document: Viral infections cause at least 10%–15% of all human carcinomas. Over the last century, the elucidation of viral oncogenic roles in many cancer types has provided fundamental knowledge on carcinogenetic mechanisms and established a basis for the early intervention of virus-related cancers. Meanwhile, rapidly evolving genome-editing techniques targeting viral DNA/RNA have emerged as novel therapeutic strategies for treating virus-related carcinogenesis and have begun showing promising results. This review discusses the recent advances of genome-editing tools for treating tumorigenic viruses and their corresponding cancers, the challenges that must be overcome before clinically applying such genome-editing technologies, and more importantly, the potential solutions to these challenges.

    Search related documents:
    Co phrase search for related documents
    • aav deliver and acute sars cov respiratory syndrome coronavirus: 1
    • aav vector and activation response: 1
    • activation response and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activation response and liver cirrhosis: 1, 2, 3
    • activation response and long period: 1, 2, 3
    • activation response and long term treatment: 1
    • acute sars cov respiratory syndrome coronavirus and liver cirrhosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute sars cov respiratory syndrome coronavirus and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute sars cov respiratory syndrome coronavirus and long problematic: 1, 2
    • acute sars cov respiratory syndrome coronavirus and long term exposure: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and long term treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute sars cov respiratory syndrome coronavirus and long terminal: 1, 2, 3, 4, 5
    • liver cirrhosis and long term treatment: 1, 2, 3